Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis

Masatoshi Hotta; Andrei Gafita; Johannes Czernin; Jeremie Calais

doi:10.2967/jnumed.121.263441

Research ArticleBRIEF COMMUNICATION

Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with ¹⁷⁷Lu-PSMA Therapy: A Multicenter Retrospective Analysis

Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine October 2022, 63 (10) 1484-1488; DOI: https://doi.org/10.2967/jnumed.121.263441

Masatoshi Hotta

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrei Gafita

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremie Calais

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Article Information

vol. 63 no. 10 1484-1488

DOI

https://doi.org/10.2967/jnumed.121.263441

PubMed

35273096

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication October 28, 2021
Accepted for publication February 22, 2022
Published online October 3, 2022.

Article Versions

previous version (March 10, 2022 - 13:10).
previous version (April 14, 2022 - 12:36).
You are viewing the most recent version of this article.

Author Information

Masatoshi Hotta,
Andrei Gafita,
Johannes Czernin and
Jeremie Calais

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

For correspondence or reprints, contact Jeremie Calais (jcalais{at}mednet.ucla.edu).

View Full Text

Statistics from Altmetric.com

Cited By...

14 Citations
18 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy

Ian Alberts, Robin Schepers, Konstantinos Zeimpekis, Hasan Sari, Axel Rominger, Ali Afshar-Oromieh

European Journal of Nuclear Medicine and Molecular Imaging 2023 50 3
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Jeremie Calais, Francesco Ceci, Steve Y. Cho, Stefano Fanti, Frederik L. Giesel, Karolien Goffin, Uwe Haberkorn, Heather Jacene, Phillip J. Koo, Klaus Kopka, Bernd J. Krause, Liza Lindenberg, Charles Marcus, Felix M. Mottaghy, Daniela E. Oprea-Lager, Joseph R. Osborne, Morand Piert, Steven P. Rowe, Heiko Schöder, Simon Wan, Hans-Jürgen Wester, Thomas A. Hope, Ken Herrmann

European Journal of Nuclear Medicine and Molecular Imaging 2023 50 5
Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer

Sazan Rasul, Alexander R. Haug

Cancers 2022 14 15
How Many Theranostics Centers Will We Need in the United States?

Johannes Czernin, Jeremie Calais

Journal of Nuclear Medicine 2022 63 6
177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers

Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher

Journal of Nuclear Medicine 2023 64 3
A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer

Ephraim E. Parent, Adam M. Kase

Cancers 2022 14 17
Outcome of Patients with PSMA PET/CT Screening Failure by VISION Criteria and Treated with 177Lu-PSMA: A Multicenter Retrospective Analysis

Oliver Sartor

Journal of Nuclear Medicine 2022 63 10
Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts

Oliver Sartor, Ali Baghian

Frontiers in Medicine 2022 9
177Lu-PSMA Therapy

Ephraim E. Parent, Bital Savir-Baruch, Isis W. Gayed, Frankis Almaguel, Bennett B. Chin, Austin R. Pantel, Evan Armstrong, Amanda Morley, Robin C. Ippisch, Robert R. Flavell

Journal of Nuclear Medicine Technology 2022 50 3
Is18F-FDG PET Needed to Assess177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis

Robert Seifert, Tugce Telli, Boris Hadaschik, Wolfgang P. Fendler, Phillip H. Kuo, Ken Herrmann

Journal of Nuclear Medicine 2023 64 5

Article usage

Article usage: March 2022 to May 2023

	Abstract	Full	Pdf
Mar 2022	2948	0	118
Apr 2022	1247	0	65
May 2022	542	0	34
Jun 2022	468	0	28
Jul 2022	309	0	21
Aug 2022	222	0	4
Sep 2022	272	0	10
Oct 2022	1421	76	81
Nov 2022	440	33	47
Dec 2022	594	22	23
Jan 2023	598	10	34
Feb 2023	512	7	12
Mar 2023	567	20	30
Apr 2023	85	288	54
May 2023	71	232	68

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue 10

October 1, 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with ¹⁷⁷Lu-PSMA Therapy: A Multicenter Retrospective Analysis

Masatoshi Hotta, Andrei Gafita, Johannes Czernin, Jeremie Calais

Journal of Nuclear Medicine Oct 2022, 63 (10) 1484-1488; DOI: 10.2967/jnumed.121.263441

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with ¹⁷⁷Lu-PSMA Therapy: A Multicenter Retrospective Analysis

Masatoshi Hotta, Andrei Gafita, Johannes Czernin, Jeremie Calais

Journal of Nuclear Medicine Oct 2022, 63 (10) 1484-1488; DOI: 10.2967/jnumed.121.263441

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

metastatic castration-resistant prostate cancer
radionuclide therapy
PSMA PET
177Lu
VISION trial

Main menu

User menu

Search

Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with ¹⁷⁷Lu-PSMA Therapy: A Multicenter Retrospective Analysis

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: March 2022 to May 2023

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords